Helping patients find the cervical cancer
resources they deserve

How do we help cervical cancer patients?

Massive Bio offers an independent cancer treatment analysis as well as free clinical trial matching for cervical cancer patients. Our patient advocates work closely with patients to gather information on their current medical status, and then will provide a list of options from available cancer clinical trials close to your home.

We can also provide a comprehensive case analysis through our Virtual Tumor Board from cancer specialists. The Virtual Tumor Board (VTB) is comprised of highly specialized oncologists from nationally-recognized Cancer Centers of Excellence. In just 7-10 days after receiving your medical records, we can get you a treatment plan without having to travel far distances and use your valuable time.

Clinical Trials

There are approximately 400 clinical trials across the US for cervical cancer. With such an extensive list, many of them could be beneficial for you. Our team of patient advocates, who are oncology nurses, and our artificial intelligence-based clinical trial matching system will find the best option for you.

Phase 1 / 2 Study of AGEN2034 in Advanced Tumors and Cervical Cancer

With just a few clicks, you can see your clinical trial matches now. Click here to use our advanced clinical trial match tool.

Cervical Cancer Facts

It is the second most common cancer type for women with 12.8% of women being diagnosed throughout their life. Even though most people think of women when it comes to cervical cancer, roughly 1% of patients are male. Over 268,000 new cases last year alone. 67% of cervical cancer patients have the subtype HR+/HER2, which makes it the most common by far considering the next most common subtype being HR-/HER2, which includes about 10% of the patient population.

Causes

HPV is the biggest risk factor directly leading to cervical cancer. Other risk factors include smoking, giving birth to multiple children, and using the oral form of contraceptives over a long period of time. Symptoms usually don’t occur until the cancer has spread to other organs, so it is difficult to diagnose in the cancer’s early stages.

Treatments

There are several forms of treatment that are common among cervical cancer patients. The form of treatment used typically depends on the stage of the cancer. These treatment options are chemotherapy, radiation therapy, immunotherapy, and surgery. While there are multiple types of surgeries that can be performed, they usually consist of removing part of or all the cervix for later stages, or attempting to remove only the cancerous cells by devices like electric currents or a scalpel.

Screening

The pap smear test is the most common form of screening for cervical cancer. This test involves gently scraping cells from the cervix to be tested for any abnormalities.

Another common way to detect cervical cancer is a standard blood test. Oncologists use a plasma thermogram to indicate any presence of cervical cancer and the stage of the cancer.

Trends

The five-year survival rate for cervical cancer patients is Nearly 66% which is slightly lower than the average five-year survival rate for all cancers (70%).

Thanks to an increase in awareness of the pap smear tests and the risk factors associated with cervical cancer, new cases have decreased from 14.8 per 100,000 women in 1975 to 6.4 per 100,000 women in 2016. Deaths have also decreased from 5.5 women per 100,000 to 2.2 per 100,000 women. Cervical cancer used to be known as one of the more deadly cancer types. Now, the survival rate is nearly even with the average survival rate for all cancer types.

Subtypes

Squamous cell carcinoma
Adenocarcinoma

Support

Our team of patient advocates can help guide you to treatment options you might not have been previously aware of. Although you might be new to cancer, we certainly are not. Navigating cancer patients through the tricky path of finding the best treatment is our goal. No two cancer patients are alike, which is why we find treatment for all of our patients based on their specific genomics, location, stage of cancer, and nearly 100 more data points.

Contact us any time at support@massivebio.com or +1 844-627-7246.